 Oragenics Incs NYSE: OGEN stabilized pre-fusion spike protein trimer generates neutralizing antibodies in mice after immunization against SARS-CoV-2 when administered with several intramuscular IM and intranasal IN adjuvants. The expression platform is developed by Oragenics Canadian collaborator and licensed from the National Institutes of Health NIH. 